LexisNexis® Legal Newsroom
Eli Lilly Loses Patent Lawsuit For Drug Strattera

INDIANAPOLIS - (AP) Eli Lilly & Co. on Thursday lowered its revenue outlook for the year after it lost a patent lawsuit over its attention deficit hyperactivity drug Strattera. The U.S. District Court for the District of New Jersey ruled against the company, saying its method-of-use patent. . . ...

Merck To Settle Suits Alleging Jaw Damage From Osteoporosis Drug

WHITEHOUSE STATION, N.J. — (Mealey's) Merck & Co. Inc. has agreed to pay $27.7 million to resolve product liability suits alleging that its osteoporosis drug Fosamax caused osteonecrosis of the jaw (ONJ), or bone death, according to a press release the company issued Dec. 9 ( In Re: Fosamax...